Literature DB >> 6489621

Problems in the serodiagnosis of canine brucellosis: dog responses to cell wall and internal antigens of Brucella canis.

L E Carmichael, S J Zoha, R Flores-Castro.   

Abstract

Three procedures are commonly used for the serodiagnosis of B. canis infection: 1) The rapid slide agglutination test (RSAT), 2) the tube agglutination test (TAT), and 3) the modified 2-mercaptoethanol tube agglutination test (2ME-TAT). Hemocultures are always essential for diagnosis. The RSAT was developed to provide a presumptive diagnosis rapidly. It has been found accurate in identifying non-infected dogs; however false positive reactions are common due to shared determinants between the surface antigens of B. canis and certain other gram-negative bacteria. The RSAT has recently been modified to include brief reaction of test sera with 2ME (0.2M) prior to adding test antigen. The modification has improved specificity, but it has not eliminated false positive reactions. The TAT and 2ME-TAT are widely used. Although there is good agreement between tests, both suffer from lack of specificity but are valuable in kennels where B. canis has been identified by blood cultures. Agarose gel immunodiffusion (AGID) tests using extracted (SDC or hot PBS) cell wall antigenic complexes reveal precipitins in the sera of infected dogs usually 8 to 12 weeks postinfection (PI) that may persist 5 years. The antigenic complexes consist of at least 3 antigens; one (antigen '2R') appears to possess high B. canis specificity. Sera from noninfected dogs also may react nonspecifically in AGID tests that employ crude SDC or PBS antigenic extracts leading to 'false positive' interpretations. Cytoplasmic antigens gave up to four precipitin lines with sera from B. canis infected dogs. The antigens (protein or glycoprotein) were present in both S and R Brucella cells, but not in other gram-negative organisms examined. AGID tests that employed cytoplasmic antigens revealed precipitins against one or more (usually 2-3) antigens from PI months 4 through 64. In some dogs, precipitins were present 12 months after the bacteremia had ceased, a time when other tests were diagnostically insignificant, or equivocal. No 'false positive' field sera reached with the cytoplasmic antigens.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6489621

Source DB:  PubMed          Journal:  Dev Biol Stand        ISSN: 0301-5149


  9 in total

Review 1.  Brucella canis: An update on research and clinical management.

Authors:  Kevin L Cosford
Journal:  Can Vet J       Date:  2018-01       Impact factor: 1.008

2.  Purification of a Brucella canis cell wall antigen by using immunosorbent columns and use of the antigen in enzyme-linked immunosorbent assay for specific diagnosis of canine brucellosis.

Authors:  T Serikawa; S Iwaki; M Mori; T Muraguchi; J Yamada
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

3.  The first case of Brucella canis in Sweden: background, case report and recommendations from a northern European perspective.

Authors:  Bodil Ström Holst; Karin Löfqvist; Linda Ernholm; Karin Eld; Maria Cedersmyg; Gunilla Hallgren
Journal:  Acta Vet Scand       Date:  2012-03-27       Impact factor: 1.695

4.  Occurrence and potential diagnostic applications of serological cross-reactivities between Brucella and other alpha-proteobacteria.

Authors:  M Victoria Delpino; Carlos A Fossati; Pablo C Baldi
Journal:  Clin Diagn Lab Immunol       Date:  2004-09

5.  Brucella canis Isolates from Canadian Dogs.

Authors:  L B Forbes; J F Pantekoek
Journal:  Can Vet J       Date:  1988-02       Impact factor: 1.008

6.  Characterization of epididymal and testicular histologic lesions and use of immunohistochemistry and PCR on formalin-fixed tissues to detect Brucella canis in male dogs.

Authors:  Andrea M Camargo-Castañeda; Lauren W Stranahan; John F Edwards; Daniel G Garcia-Gonzalez; Leonardo Roa; Lisa M Avila-Granados; Martha E Hensel; Angela M Arenas-Gamboa
Journal:  J Vet Diagn Invest       Date:  2021-01-19       Impact factor: 1.279

7.  Diagnosis of canine brucellosis: comparison between serological and microbiological tests and a PCR based on primers to 16S-23S rDNA interspacer.

Authors:  L B Keid; R M Soares; N R Vieira; J Megid; V R Salgado; S A Vasconcellos; M da Costa; F Gregori; L J Richtzenhain
Journal:  Vet Res Commun       Date:  2007-02-16       Impact factor: 2.816

8.  Brucellosis in Dogs and Public Health Risk.

Authors:  Martha E Hensel; Maria Negron; Angela M Arenas-Gamboa
Journal:  Emerg Infect Dis       Date:  2018-08       Impact factor: 6.883

9.  MALDI-TOF MS and genomic analysis can make the difference in the clarification of canine brucellosis outbreaks.

Authors:  David Attuy Vey da Silva; Holger Brendebach; Josephine Grützke; Ralf Dieckmann; Rodrigo Martins Soares; Julia Teresa Ribeiro de Lima; Lara Borges Keid; Dirk Hofreuter; Sascha Al Dahouk
Journal:  Sci Rep       Date:  2020-11-06       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.